Title of article
Vitamin D3 Administration to Patients with Confirmed COVID-19
Author/Authors
RASHEDI, Jalil Department of Laboratory Sciences - School of Paramedicine - Tabriz University of Medical Sciences, Tabriz , MAHDAVI POOR, Behroz Department of Laboratory Sciences - School of Paramedicine - Tabriz University of Medical Sciences, Tabriz , ASGHARZADEH, Mohammad Tabriz University of Medical Sciences, Tabriz
Pages
2
From page
141
To page
142
Abstract
In the last month of 2019, a newly identified ill-ness termed coronavirus disease 2019 (COVID-19) spread rapidly through the world. A new coronavirus, the cause of the disease, was identi-fied as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This virus uses a monocarboxypeptidase named angiotensin-converting enzyme 2 (ACE2) as a functional re-ceptor, expressed by epithelial cells of the lung, intestine, kidney, and blood vessels, to facilitate viral entry into target cells.
Keywords
COVID-19 , Vitamin D3 , ACE2s , SARS-CoV-2
Journal title
Astroparticle Physics
Serial Year
2020
Record number
2490504
Link To Document